Randomized Trial of Osteoporosis Intervention Strategies in Hip Fracture Patients - Full Text View

Sponsors and Collaborators:	University of Alberta Alberta Heritage Foundation for Medical Research Royal Alexandra Hospital
Information provided by:	University of Alberta
ClinicalTrials.gov Identifier:	NCT00175175

Purpose

Patients with hip fractures have suffered the most devastating consequence of osteoporosis; and yet, they are rarely if ever tested or treated for the condition, even though they remain at high risk of recurrent fracture.

We hypothesize that, compared with usual care, an allied health professional-run osteoporosis service (case management) will be able to increase testing and treatment of osteoporosis in patients at high risk of fracture.

Condition	Intervention
Osteoporosis Hip Fracture	Behavioral: Allied health professional-run osteoporosis service ("case-management")

Study Type:	Interventional
Study Design:	Treatment, Randomized, Single Blind, Active Control, Parallel Assignment, Safety/Efficacy Study
Official Title:	Randomized Trial of Osteoporosis Intervention Strategies in Hip Fracture Patients

Resource links provided by NLM:

MedlinePlus related topics: Fractures Hip Injuries and Disorders Hip Replacement Osteoporosis

U.S. FDA Resources

Further study details as provided by University of Alberta:

Primary Outcome Measures:

The proportion of patients taking bisphosphonate therapy within 6 months of hip fracture

Secondary Outcome Measures:

Proportion of patients taking prescription osteoporosis treatment at 6 months and 12 months
Proportion in receipt of a BMD test at 6 months and 12 months
Proportion still adherent to osteoporosis treatments at 6 months and 12 months
Proportion of patients with recurrent fractures at 6 months and 12 months
Cost effectiveness analyses

Estimated Enrollment:	220
Study Start Date:	March 2002

Detailed Description:

Patients with hip fractures have suffered the most devastating consequence of osteoporosis; and yet, they are rarely if ever tested or treated for the condition, even though they remain at high risk of recurrent fracture.

We hypothesize that, compared with usual care, an allied health professional-run osteoporosis service (case management) will be able to increase testing and treatment of osteoporosis in patients at high risk of fracture.

Eligibility

Ages Eligible for Study:	50 Years and older
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

hip fracture patient > 50 years of age
able to give consent (or proxy consent available)
lives within health region
no contraindications to bisphosphonate therapy

Exclusion Criteria:

refuses to participate or consent
dementia or delirium without a proxy consent available
nursing home or longterm care
pathologic fracture
chronic glucocorticoid use
already receiving prescription osteoporosis treatment (calcium and vitamin D do not preclude inclusion)

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00175175

Locations

Canada, Alberta
University of Alberta Hospitals
Edmonton, Alberta, Canada, T6G 2B7

Sponsors and Collaborators

University of Alberta

Alberta Heritage Foundation for Medical Research

Royal Alexandra Hospital

Investigators

Principal Investigator:

Sumit R Majumdar, MD, MPH

University of Alberta

More Information

No publications provided by University of Alberta

Additional publications automatically indexed to this study by National Clinical Trials Identifier (NCT ID):

Morrish DW, Beaupre LA, Bell NR, Cinats JG, Hanley DA, Harley CH, Juby AG, Lier DA, Maksymowych WP, Majumdar SR. Facilitated bone mineral density testing versus hospital-based case management to improve osteoporosis treatment for hip fracture patients: additional results from a randomized trial. Arthritis Rheum. 2009 Feb 15;61(2):209-15.

Majumdar SR, Lier DA, Beaupre LA, Hanley DA, Maksymowych WP, Juby AG, Bell NR, Morrish DW. Osteoporosis case manager for patients with hip fractures: results of a cost-effectiveness analysis conducted alongside a randomized trial. Arch Intern Med. 2009 Jan 12;169(1):25-31.

Majumdar SR, Beaupre LA, Harley CH, Hanley DA, Lier DA, Juby AG, Maksymowych WP, Cinats JG, Bell NR, Morrish DW. Use of a case manager to improve osteoporosis treatment after hip fracture: results of a randomized controlled trial. Arch Intern Med. 2007 Oct 22;167(19):2110-5.

Study ID Numbers:	AHFMR #200100791
Study First Received:	September 9, 2005
Last Updated:	September 13, 2006
ClinicalTrials.gov Identifier:	NCT00175175 History of Changes
Health Authority:	Canada: Health Canada

Keywords provided by University of Alberta:

osteoporosis treatment
osteoporosis testing
hip fracture
quality improvement

Study placed in the following topic categories:

Hip Fractures
Femoral Fractures
Musculoskeletal Diseases
Fractures, Bone
Wounds and Injuries

Disorders of Environmental Origin
Osteoporosis
Bone Diseases, Metabolic
Leg Injuries
Bone Diseases

Additional relevant MeSH terms:

Hip Fractures
Femoral Fractures
Musculoskeletal Diseases
Fractures, Bone
Wounds and Injuries
Disorders of Environmental Origin

Osteoporosis
Bone Diseases, Metabolic
Leg Injuries
Hip Injuries
Bone Diseases

ClinicalTrials.gov processed this record on July 02, 2009